Smith Kellie N, Mailliard Robbie B, Rinaldo Charles R
Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA; Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA.
Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA.
For Immunopathol Dis Therap. 2015;6(1-2):67-77. doi: 10.1615/ForumImmunDisTher.2016014160.
Despite the success of combination antiretroviral therapy (cART), a latent viral reservoir persists in HIV-1-infected persons. Unfortunately, endogenous cytotoxic T lymphocytes (CTLs) are unable to control viral rebound when patients are removed from cART. A "kick and kill" strategy has been proposed to eradicate this reservoir, whereby infected T cells are induced to express viral proteins via latency-inducing drugs followed by their elimination by CTLs. It has yet to be determined if stimulation of existing HIV-1-specific CTL will be sufficient, or if new CTLs should be primed from naïve T cells. In this review, we propose that dendritic cells (DCs), the most potent antigen presenting cells, act as dog trainers and can induce T cells (the dogs) to do magnificent tricks. We propose the hypothesis that an HIV-1 cure will require targeting of naïve T cells and will necessitate "teaching new dogs new tricks" while avoiding activation of potentially dysfunctional endogenous memory CTLs (letting the sleeping dogs lie).
尽管联合抗逆转录病毒疗法(cART)取得了成功,但在HIV-1感染者体内仍存在潜伏的病毒库。不幸的是,当患者停止使用cART时,内源性细胞毒性T淋巴细胞(CTL)无法控制病毒反弹。有人提出了一种“激活并清除”策略来根除这个病毒库,即通过潜伏期诱导药物诱导受感染的T细胞表达病毒蛋白,随后由CTL将其清除。目前尚不清楚刺激现有的HIV-1特异性CTL是否足够,或者是否应该从初始T细胞中启动新的CTL。在这篇综述中,我们提出,树突状细胞(DC)作为最强大的抗原呈递细胞,就像驯犬师一样,可以诱导T细胞(即“狗”)做出惊人的把戏。我们提出一个假设,即治愈HIV-1需要针对初始T细胞,并且需要“教新狗新把戏”,同时避免激活潜在功能失调的内源性记忆CTL(别惹麻烦)。